Sector revisions Myriad Genetics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-13 pm EST			5-day change	1st Jan Change
4.490 ^USD	-0.88%		-12.30%	-26.99%

Jan. 27	Myriad Genetics, Inc. Advances Mrd Commercialization Timeline, Bolstered by New Study Data	CI
Jan. 14	Myriad Genetics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 05:15 PM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Visibility	Nbr of analysts
MYRIAD GENETICS, INC.				10
GUARDANT HEALTH, INC.				21
BIOMÉRIEUX				13
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.				10
CARIS LIFE SCIENCES, INC.			-	9
DIASORIN S.P.A.				12
LANTHEUS HOLDINGS, INC.				13
AUTOBIO DIAGNOSTICS CO., LTD.				4
ANDON HEALTH CO., LTD.	-	-	-	-
10X GENOMICS, INC.				14
BEIJING HOTGEN BIOTECH CO., LTD.			-	-
VCANBIO CELL & GENE ENGINEERING CORP., LTD			-	-
SANSURE BIOTECH INC.				2
SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.			-	1
VITROLIFE AB				4
GUANGZHOU WONDFO BIOTECH CO.,LTD			-	1
AMOY DIAGNOSTICS CO., LTD.				3
BEIJING STRONG BIOTECHNOLOGIES,INC.			-	-
Average				8
Weighted average by Cap.				12